These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7214373)

  • 1. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM
    Cancer Treat Rev; 1980 Dec; 7(4):167-76. PubMed ID: 7214373
    [No Abstract]   [Full Text] [Related]  

  • 2. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Venditti JM; Macdonald JS; Muggia FM; Henney JE; Devita VT
    Eur J Cancer (1965); 1981 Feb; 17(2):129-42. PubMed ID: 6894902
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective screening program: current screening and its status.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1981; 76():176-91. PubMed ID: 7232850
    [No Abstract]   [Full Text] [Related]  

  • 4. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
    Venditti JM; Wesley RA; Plowman J
    Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 6. Some thoughts on experimental models and their clinical correlations.
    Carter SK
    Eur J Cancer (1965); 1973; 9(11-12):833-41. PubMed ID: 4804310
    [No Abstract]   [Full Text] [Related]  

  • 7. The new NCI screen and its implications for clinical evaluation.
    Goldin A; Venditti JM
    Recent Results Cancer Res; 1980; 70():5-20. PubMed ID: 7355249
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 9. The National Cancer Institute's Natural Products Antineoplastic Development Program.
    Douros J; Suffness M
    Recent Results Cancer Res; 1980; 70():21-44. PubMed ID: 7355247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A.
    Venditti JM; Johnson RK
    Recent Results Cancer Res; 1978; 63():49-57. PubMed ID: 705014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening at the National Cancer Institute.
    Goldin A; Venditti JM; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigational drugs under study by the United States National Cancer Institute.
    Carter SK; Slavik M
    Cancer Treat Rev; 1976 Mar; 3(1):43-60. PubMed ID: 62615
    [No Abstract]   [Full Text] [Related]  

  • 14. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of cytotoxic drugs.
    Von Hoff DD; Rozencweig M; Muggia FM
    Cancer Treat Rev; 1979 Jun; 6 Suppl():1-8. PubMed ID: 498161
    [No Abstract]   [Full Text] [Related]  

  • 16. The National Cancer Chemotherapy Program.
    Frei E
    Science; 1982 Aug; 217(4560):600-6. PubMed ID: 7046055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness and limitations of murine tumor models for the identification of new antitumor agents.
    Goldin A; Johnson RK; Venditti JM
    Antibiot Chemother (1971); 1980; 28():1-7. PubMed ID: 6998358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor screening procedures of the National Cancer Institute.
    Schepartz SA
    Jpn J Antibiot; 1977 Dec; 30 Suppl():35-40. PubMed ID: 612710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 20. New natural products under development at the National Cancer Institute.
    Douros J; Suffness M
    Recent Results Cancer Res; 1981; 76():153-75. PubMed ID: 7232848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.